The largest database of trusted experimental protocols

28 protocols using mog35 55

1

Tracking Antigen-Specific T Cell Recruitment to CNS

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine whether myelin specific T cells require antigen-specific APCs for recruitment to the CNS, EAE was actively induced using a combination of two antigenic peptides in 8–12 week old female recipient mice. 3×106 naïve 2D2-CFP and 3×106 naïve OTII-GFP CD4+ T cells were isolated separately by negative depletion using Dynal beads and co-injected into naive recipient mice. 24 hours later, an emulsion of 200 μg MOG35-55 only, 10 μg OVA323-339 only, or 200 μg MOG35-55 and 10 μg OVA323-339 combined (Anaspec, San Jose, CA, USA) with CFA (8 mg/mL H37RA and IFA; Difco Laboratories, Detroit, MI, USA) was injected s.c. bilaterally on the lower back of the recipient mice. Control mice were injected s.c. bilaterally with an emulsion of PBS and CFA. 100 ng PTx (List Biological Laboratories, Inc, Campbell, CA, USA) was administered i.p. on days 0, 1 and 2 to induce EAE.
+ Open protocol
+ Expand
2

IL-2:anti-IL-2 mAb Complexes for Thymic Slices

Check if the same lab product or an alternative is used in the 5 most similar protocols
IL-2:anti-IL-2 mAb complexes were described previously26 (link),27 (link). Briefly, 1.5 μg IL-2 recombinant protein (eBioscience) was incubated with 7.5 μg of functional grade anti-IL-2 mAb (clone JES6-1, eBioscience) for 30 min at 37 °C. Complexes were added directly to thymic slices (10 μl/slice) daily over the course of the experiment. Mouse MOG 35–55 and chicken OVA 323–339 peptides were purchased from Anaspec. Peptide was overlaid on thymic slices for 10–30 min after thymocyte migration into the slice.
+ Open protocol
+ Expand
3

Quantification of Cytokine Secretion and Receptor Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine IFN-γ and IL-17 secretion, cells isolated from CNS draining lymph nodes were adjusted to 5 × 106 cells (c)/ml in RPMI 1640 medium, containing 8.6% FCS, 4 mM glutamine, 1 mM sodium pyruvate, 0.1 mM MEM non-essential amino acids, 200 μg/ml penicillin, 200 μg/ml streptomycin, 25 μg/ml gentamicin, and 50 μM 2-ME and stimulated with MOG35–55 (MEVGWYRSPFSRVVHLYRNGK) (Ana Spec, Fremont, CA) in Costar® 96-well round-bottom culture plates (Thermo Fisher Scientific Inc., Waltham, MA) for 96 h. Cell-free supernatants were collected and cytokines were quantified by ELISA using Ready-SET-Go!® ELISA kits (eBioscience, San Diego, CA). To determine TNF, TNFR1, and TNFR2 concentrations, serum samples were collected and quantified using eBioscience Ready-SET-Go!® ELISA kits (TNF and TNFR2) or the mouse TNFR1 DuoSet® ELISA kit (R&D Systems, Minneapolis, MN). All cell-free culture supernatants and serum samples were stored at −80°C until use. The absorbance (450 nm) minus background (570 nm) of the colorimetric reactions were quantified using a Synergy 4 spectrophotometry microplate reader (BioTek, Winooski, VT). The lower limit of sensitivity of the TNF assay was 8 pg/ml. The recognition of TNF by the Ready-SET-Go!® assay is not affected by 1000-fold excess soluble TNFR1 or TNFR2.
+ Open protocol
+ Expand
4

Induction of Experimental Autoimmune Encephalomyelitis in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female mice (8–10 wk old) were injected s.c. in two locations in the dorsal flank with an emulsion containing 200 µg of MOG35–55 (Anaspec, Fremont, CA) and CFA (Difco, Detroit, MI) as previously described (26 , 27 (link)). Pertussis toxin (400 ng; List Biological Laboratories, Campbell, CA) was administered i.p. on days 0 and 2. CD4+ T cell–reconstituted Rag1−/− mice were immunized with 150 µg of MOG peptide emulsified in CFA at day 0 and day 7 as previously described (28 (link)). Pertussis toxin was given i.p. at day 1 and day 8 (500 ng per injection). Mice were monitored daily and the disease was scored on a scale of 0–5 as follows: 1, limp tail; 2, hindlimb paresis; 3, hindlimb paralysis; 4, tetraplegia; 5, moribund (27 (link), 29 (link)).
+ Open protocol
+ Expand
5

IL-2:anti-IL-2 mAb Complexes for Thymic Slices

Check if the same lab product or an alternative is used in the 5 most similar protocols
IL-2:anti-IL-2 mAb complexes were described previously26 (link),27 (link). Briefly, 1.5 μg IL-2 recombinant protein (eBioscience) was incubated with 7.5 μg of functional grade anti-IL-2 mAb (clone JES6-1, eBioscience) for 30 min at 37 °C. Complexes were added directly to thymic slices (10 μl/slice) daily over the course of the experiment. Mouse MOG 35–55 and chicken OVA 323–339 peptides were purchased from Anaspec. Peptide was overlaid on thymic slices for 10–30 min after thymocyte migration into the slice.
+ Open protocol
+ Expand
6

Experimental Autoimmune Encephalomyelitis Induction

Check if the same lab product or an alternative is used in the 5 most similar protocols
EAE was actively induced in 6- to 10-week old Sarm1 knockout mice and wild type littermates by subcutaneous injection of 200 μg of myelin oligodendrocyte glycoprotein peptide 35–55 (MOG35-55, Anaspec) emulsified in complete Freund’s adjuvant (CFA) containing 500 μg M. Tuberculosis H37 RA (Difco) and intraperitoneal injection of 300 ng pertussis toxin (List Biological Laboratories), followed by a second intraperitoneal injection of 300 ng pertussis toxin 2 days later. Female and male mice were induced. Animals that died prior to onset of clinical EAE were included in the mortality analysis, but excluded from analysis of EAE clinical scores. Mice were scored daily as follows: 0 –no overt signs of disease; 1 –limp tail or loss of righting reflex but not both; 2 –limp tail and loss of righting reflex; 3 –partial hind limb paralysis; 4 –complete hind limb paralysis; 5 –moribund state or death. Clinical score rater was blinded to genotype. Primary clinical outcome was the mean total or cumulative clinical score defined as the sum of daily clinical scores from induction until 42 days post-induction [16 (link)].
+ Open protocol
+ Expand
7

Induction of Experimental Autoimmune Encephalomyelitis

Check if the same lab product or an alternative is used in the 5 most similar protocols
RGC-32 KO and WT female mice (8–10 weeks old) were injected subcutaneously in two locations in the dorsal flank with an emulsion containing 200 μg of MOG35–55 (Anaspec, Fremont, CA) and complete Freund’s adjuvant (CFA) (Difco, Detroit, MI) as previously described (23 (link)). Pertussis toxin (400 ng; List Biological Laboratories, Campbell, CA) was administered intraperitoneally on days 0 and 2. Mice were monitored daily, and the disease was scored on a scale of 0–5 as follows: 1—limp tail; 2—hindlimb paresis; 3—hindlimb paralysis; 4—tetraplegia; 5—moribund. Age- and sex-matched uninjected mice were used as controls (day 0).
+ Open protocol
+ Expand
8

Induction of Experimental Autoimmune Encephalomyelitis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal use and relevant experimental procedures were approved by the Institutional Animal Care and Use Committee, Hallym University (Protocol number Hallym 2011-68). This study was conducted in accordance with the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines [25 ]. C57BL/6 female mice, aged 8 weeks, were purchased from DBL (Chungcheongbuk, Korea), were housed in a temperature- and humidity-controlled environment, and supplied with Purina diet (Purina, Gyeonggi, Korea) and water ad libitum. Mice were immunized on day 0 by subcutaneous injection of 200 μL of a mixture of recombinant myelin oligodendrocyte glycoprotein (MOG (35–55), 2 mg/mL) (AnaSpec, CA) and complete Freund's adjuvant containing 400 μg of Mycobacterium tuberculosis H37RaA (Difco Laboratories, MI) according to the manufacturer's instruction [26 (link)]. Pertussis toxin (List Biological Laboratories, CA) was intraperitoneally administered at a dose of 400 ng on postimmunization days 0 and 2. A booster injection was given on day 7 after the initial immunization.
+ Open protocol
+ Expand
9

Chronic EAE Induction in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
The animal experiments were approved by the St. Luke's Roosevelt Hospital Center IACUC. Chronic EAE was induced in C57BL/6 wild‐type female mice (aged 6–8 weeks) obtained from Jackson Laboratory (Bar Harbor, ME) as follows. The animals were subcutaneously immunized with 200 µg of myelin oligodendrocyte glycoprotein 35–55 (MOG35–55, AnaSpec, Fremont, CA, USA) in incomplete Freund adjuvant (IFA, Sigma, St. Louis, MO, USA) plus 8 mg/ml mycobacterium tuberculosis (strain H37RA, Difo), with i.v. inoculation of 300 ng Bordetella pertussis toxin (PTX, Sigma) at the time of immunization and 48 h thereafter, as previously reported 8. Disability was scored using a 0–13 EAE scale 9, which was modified from the standard 0–5 scale 9. The scorer was blinded to treatment groups. Mice were divided into control (PBS + 10% DMSO, n = 15) and CGS‐21680 (50 µg/kg, i.p., daily from the beginning of immunization [Day 0] to Day 20; Abcam, Cambridge, MA, USA; n = 15) 9. CGS‐21680 doses were based on previous in vitro studies 10.
+ Open protocol
+ Expand
10

Myelin Oligodendrocyte Glycoprotein-Induced EAE Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
EAE was induced in C57BL/6 female mice by injecting them with 200µg of MOG35-55 (myelin oligodendrocyte glycoprotein 35-55; AnaSpec, USA) peptide emulsified in incomplete Freund’s adjuvant (IFA) (Sigma, St Louis, MO, USA) containing 3mg/ml inactivated Mycobacterium tuberculosis H37Ra (Becton, Dickinson and company, Sparks, MD 21152 USA) subcutaneously at the back on day 0, followed by intraperitoneal injections of 500ng of pertussis toxin (Sigma, St Louis, MO, USA) on days 0 and 2. Control mice received a subcutaneous injection of IFA at the back. Mice were weighed daily and monitored for disease progression using the standard clinical scoring system of paralytic EAE: score 0, no disease; 1, flaccid tail; 2, hind limbs weakness and wobbly gait; 3, paralysis of hind limbs with residual mobility in both legs; 4, both hind legs completely paralyzed and partial front limb paralysis; 5, moribund or death (7 (link)). Wet food pellets were provided inside the cage for mice with advanced disease scores (score 3 and above).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!